» Articles » PMID: 18783824

The C5b-9 Membrane Attack Complex of Complement Activation Localizes to Villous Trophoblast Injury in Vivo and Modulates Human Trophoblast Function in Vitro

Overview
Journal Placenta
Publisher Elsevier
Date 2008 Sep 12
PMID 18783824
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The complement system plays an important role in normal human pregnancy. Uncontrolled activation of this system has been associated with many disease states. We tested the hypothesis that the C5b-9 membrane attack complex (MAC) localizes to sites of villous injury and modulates trophoblast function. Placental sections from pregnancies with no complications, intrauterine growth restriction, or preeclampsia were immunostained and the surface density for MAC and fibrin was determined by morphometric analysis. Primary cytotrophoblasts from term placentas were cultured in a FiO(2) of <1%, 8% and 20% with 10% human serum containing active MAC or heat-inactivated control serum. Immunofluorescent MAC binding to trophoblast was quantified, and the neoepitopes formed in cytokeratin 18 filaments and poly-ADP-ribose polymerase during apoptosis were used to measure cell death. Trophoblast differentiation was assessed by HCG secretion, formation of syncytia, and expression of syncytin. MAC localized to fibrin deposits in normal placentas, and especially in placentas from IUGR and preeclampsia. MAC binding to cytotrophoblasts was inversely proportional to FiO(2) and enhanced apoptosis. MAC increased markers of differentiation in cultures at 72h (medium HCG, syncytia and syncytin expression). Our findings demonstrate that MAC associates with fibrin deposits at sites of villous injury in vivo. Hypoxia also enhances MAC deposition in cultured trophoblasts and MAC alters trophoblast function in a phenotype specific manner.

Citing Articles

Circulating extracellular vesicles and neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia.

Ramos A, Youssef L, Molina P, Torramade-Moix S, Martinez-Sanchez J, Moreno-Castano A Front Immunol. 2024; 15:1488127.

PMID: 39735539 PMC: 11671372. DOI: 10.3389/fimmu.2024.1488127.


Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study.

Venou T, Vetsiou E, Varelas C, Daniilidis A, Psarras K, Koravou E J Pers Med. 2024; 14(4).

PMID: 38673014 PMC: 11051193. DOI: 10.3390/jpm14040387.


Exposure to endocrine disrupting chemicals impacts immunological and metabolic status of women during pregnancy.

Merrill A, Sobolewski M, Susiarjo M Mol Cell Endocrinol. 2023; 577:112031.

PMID: 37506868 PMC: 10592265. DOI: 10.1016/j.mce.2023.112031.


The role of immune cells and mediators in preeclampsia.

Deer E, Herrock O, Campbell N, Cornelius D, Fitzgerald S, Amaral L Nat Rev Nephrol. 2023; 19(4):257-270.

PMID: 36635411 PMC: 10038936. DOI: 10.1038/s41581-022-00670-0.


The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia.

David M, Naicker T Obstet Gynecol Sci. 2023; 66(4):253-269.

PMID: 36597584 PMC: 10375220. DOI: 10.5468/ogs.22175.


References
1.
Nelson D . Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta. 1996; 17(7):387-91. DOI: 10.1016/s0143-4004(96)90019-3. View

2.
Levy R, Smith S, Chandler K, Sadovsky Y, Nelson D . Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol. 2000; 278(5):C982-8. DOI: 10.1152/ajpcell.2000.278.5.C982. View

3.
Richani K, Romero R, Soto E, Espinoza J, Nien J, Chaiworapongsa T . Unexplained intrauterine fetal death is accompanied by activation of complement. J Perinat Med. 2005; 33(4):296-305. DOI: 10.1515/JPM.2005.052. View

4.
Miller R, Genbacev O, Turner M, Aplin J, Caniggia I, Huppertz B . Human placental explants in culture: approaches and assessments. Placenta. 2005; 26(6):439-48. DOI: 10.1016/j.placenta.2004.10.002. View

5.
. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2005; 99(1):159-67. DOI: 10.1016/s0029-7844(01)01747-1. View